Frequently Asked Questions about Disc Medicine, Inc. (IRON)

Name: Disc Medicine, Inc. (IRON) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Disc Medicine, Inc. (IRON) do?

Accepted Answer

Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targe...

Question 2

Is Disc Medicine, Inc. (IRON) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of IRON reveals an Altman Z-Score of 21.88 and a Piotroski F-Score of 3/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if IRON fits their risk profile.

Question 3

What is the current P/E ratio for IRON?

Accepted Answer

As of the latest trading session, Disc Medicine, Inc. (IRON) has a trailing P/E ratio of -11.01.

Question 4

Who is the CEO of Disc Medicine, Inc.?

Accepted Answer

The current Chief Executive Officer of Disc Medicine, Inc. is John D. Quisel.

Question 5

What was IRON's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Disc Medicine, Inc. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does IRON pay a dividend?

Accepted Answer

Disc Medicine, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does IRON have?

Accepted Answer

In its latest reporting period, Disc Medicine, Inc. generated $-0.18B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Disc Medicine, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Disc Medicine, Inc. (IRON) is currently 3.16.

Question 9

What is the Price-to-Sales (P/S) ratio of IRON?

Accepted Answer

Based on trailing twelve-month data, Disc Medicine, Inc. (IRON) trades at a Price-to-Sales (P/S) ratio of 0.00.

Question 10

What is Disc Medicine, Inc.'s Return on Equity (ROE)?

Accepted Answer

Disc Medicine, Inc. (IRON) has a Return on Equity (ROE) of -32.80%, representing its profitability relative to shareholder equity.